Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Gritstone bio, Inc. (GRTS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/24/2023 |
4
| Economides Vassiliki (See Remarks) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Bought 12,000 shares
@ $1.9024, valued at
$22.8k
|
|
02/06/2023 |
4
| Jooss Karin (See Remarks) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 252,763 shares
@ $0 |
|
02/06/2023 |
4
| Jones Erin (See Remarks) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 252,845 shares
@ $0 |
|
02/06/2023 |
4
| Hawryluk Matthew (See Remarks) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 191,771 shares
@ $0 |
|
02/06/2023 |
4
| Economides Vassiliki (See Remarks) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 179,058 shares
@ $0 |
|
02/06/2023 |
4
| Cho James (Chief Accounting Officer) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 64,515 shares
@ $0 |
|
02/06/2023 |
4
| Allen Andrew R (President and CEO) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 738,550 shares
@ $0 |
|
08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/20/2022 |
4
| Thompson Rahsaan (EVP and General Counsel) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 19,240 shares
@ $0 Granted 115,440 options to buy
@ $5.46, valued at
$630.3k
|
|
04/20/2022 |
4
| Jooss Karin (See Remarks) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 27,600 shares
@ $0 Granted 165,600 options to buy
@ $5.46, valued at
$904.2k
|
|
04/20/2022 |
4
| Jones Erin (COO) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 27,169 shares
@ $0 Granted 163,013 options to buy
@ $5.46, valued at
$890.1k
|
|
04/20/2022 |
4
| Hawryluk Matthew (See Remarks) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 21,612 shares
@ $0 Granted 129,675 options to buy
@ $5.46, valued at
$708k
|
|
04/20/2022 |
4
| Economides Vassiliki (EVP & CFO) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 23,000 shares
@ $0 Granted 138,000 options to buy
@ $5.46, valued at
$753.5k
|
|
04/20/2022 |
4
| Cho James (Chief Accounting Officer) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 4,400 shares
@ $0 Granted 26,300 options to buy
@ $5.46, valued at
$143.6k
|
|
04/20/2022 |
4
| Allen Andrew R (President and CEO) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 70,000 shares
@ $0 Granted 410,000 options to buy
@ $5.46, valued at
$2.2M
|
|
01/04/2022 |
4
| Fisher Clare (Director) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 38,000 options to buy
@ $12.86, valued at
$488.7k
|
|
12/03/2021 |
4
| Jones Erin (COO) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Sold 1,000 shares
@ $13.01, valued at
$13k
Exercised 1,000 options to buy
@ $0.345, valued at
$345 |
|
11/19/2021 |
4
| Jones Erin (See Remarks) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 25,900 shares
@ $0 |
|
11/19/2021 |
4
| Yabannavar Vijay (See Remarks) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 28,000 shares
@ $0 |
|
11/19/2021 |
4
| Agarwal Shefali (Director) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 937 options to buy
@ $9.86, valued at
$9.2k
|
|
11/19/2021 |
4
| Agarwal Shefali (Director) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 38,000 options to buy
@ $9.48, valued at
$360.2k
|
|
11/19/2021 |
4
| Rousseau Raphael (See Remarks) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 29,700 shares
@ $0 |
|
11/19/2021 |
4
| Yelensky Roman (See Remarks) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 27,400 shares
@ $0 |
|
11/19/2021 |
4
| Thompson Rahsaan (EVP and General Counsel) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 25,500 shares
@ $0 |
|
11/19/2021 |
4
| Rizvi Naiyer (Director) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 937 options to buy
@ $9.86, valued at
$9.2k
|
|
11/19/2021 |
4
| Rizvi Naiyer (Director) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 38,000 options to buy
@ $9.48, valued at
$360.2k
|
|
11/19/2021 |
4
| Li Judith (Director) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 19,000 options to buy
@ $9.86, valued at
$187.3k
|
|
11/19/2021 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Gritstone bio, Inc.
Txns:
| Granted 19,000 options to buy
@ $9.86, valued at
$187.3k
|
|
|
|
|